Infographic: State Efforts to Address Drug Prices

The National Academy for State Health Policy (NASHP), a non-profit, non-partisan academy of state health policymakers, reports the following successful 2017 drug pricing initiatives passed at the state level.

Related Content:

Policy

BioRationality: The Urgency of Removing Clinical Efficacy Studies

Eye on Pharma: Interchangeability Labels and Expanded Biosimilar Partnerships

British Columbia’s Biosimilar Policy Shows No Impact on Hospital Visits